CADALIMOGENE IXALENTIVEC
UNII BUR1ANM8G4

Substance Identification & Data

This profile provides standardized clinical and technical data for Cadalimogene Ixalentivec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BUR1ANM8G4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2137091-21-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BUR1ANM8G4
CAS Registry Number
2137091-21-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CADALIMOGENE IXALENTIVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10984
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
ITIS TSN
180092
Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.
NCBI Taxonomy
9606
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cadalimogene Ixalentivec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CADALIMOGENE IXALENTIVEC

Common Names & Synonyms

CADALIMOGENE IXALENTIVEC [INN]

Systematic Nomenclature

A RECOMBINANT DENDRITIC CELL-TARGETING, NON-REPLICATING AND INTEGRATION-DEFICIENT LENTIVIRAL VECTOR, ENCODING THE CANCER TESTIS (CT) ANTIGEN NY-ESO-1, UNDER THE CONTROL OF AN EUKARYOTIC UBIQUITIN INTRON-DELETED PROMOTER